FDAFDA · Food and drugs·Recall number D-0959-2017
EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc. New York, NY 10017 USA, NDC 0003-0894-21
Published July 19, 2017 · Recall initiated: June 5, 2017
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets.
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Manufacturer
- Bristol-myers Squibb Company
- Distributor
- Nationwide in the US
- Lot
- Lot: HN0063, EXP. 09/2019
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.